JP Morgan Maintains Overweight on Solid Biosciences, Raises Price Target to $12

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Solid Biosciences (NASDAQ: SLDB) and raised the price target from $11 to $12. This adjustment reflects the analyst's positive outlook on the company's performance.